Transcranial Pulse Stimulation (TPS): first NEUROLITH system installed in Switzerland
Transcranial Pulse Stimulation (TPS®
) for the treatment of Alzheimer's patients is now also available for patients in Switzerland. In early February 2021, the first NEUROLITH®
system was successfully installed in the Praxis Alexander Russ
practice A. Russ has already treated the first patients and reports that TPS®
is in high demand: »We have numerous appointment requests from patients from the greater Zurich area, but also from the entire Lake Constance region and neighbouring southern Germany.«
In addition to Switzerland, TPS®
is already available in Germany, Austria, Spain, France, Denmark, Portugal, England, Kuwait, Hong Kong, China and Canada. Another 15 installations are firmly planed until the middle of this year.
About TPS® treatment
In 2018, Transcranial Pulse Stimulation (TPS®
) with the NEUROLITH®
system was the first, and hitherto only, procedure of its kind to obtain market authorization for the »treatment of the central nervous system of patients with Alzheimer’s disease«.
can stimulate deep cerebral regions, reaching as much as 8 cm into the brain. Owing to the short duration of the TPS®
stimulation, tissue heating is avoided. The pulses applied to the treatment area thus develop their maximum clinical effectiveness. TPS®
treatment is performed through the closed skull. In studies, TPS®
treatment has been shown to significantly improve CERAD test performance and to reduce Beck’s depression index in patients with mild to moderate dementia.